Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Neoplasma Vol.54, p.353-358, 2007 |
||
Title: Prognostic factors in stage-i (T1N0) breast carcinoma patients: who needs adjuvant systemic treatment? | ||
Author: E. YILDIRIM, U. BERBEROGLU | ||
Abstract: There is no consensus about the need of adjuvant therapy in T1N0 breast carcinoma patients. To select a subgroup of these
patients who may benefit from adjuvant systemic therapy, prognostic factor analyses were carried out using chi-square test
and Cox regression analysis in 187 patients’ data in this retrospective study. Primary endpoint was distant metastasis (DM).The
multivariate Cox analysis showed that age group (≤35 years vs >35 years, p=0.01; Hazard Ratio [HR], 15.4; 95% Confidence
Interval [CI], 1.8-133.0), tumor size (>1 cm vs ≤1 cm, p=0.002; HR,3.5; CI:1.2-13.4) and LVI (yes vs no, p=0.002; HR,34.7;
CI:3.6-326.0) were strongly associated with DM. From this analysis, a risk estimation model for DM was constructed.
Whereas patients at low risk had a 96% distant metastasis-free survival, this rate for those at high risk had a 37% (p<0.00001).
According to the proposed model including age, tumor size and LVI, the patients at high risk might benefit from adjuvant
systemic therapy. |
||
Keywords: breast carcinoma, stage 1, prognostic factors, risk estimation, adjuvant therapy. | ||
Year: 2007, Volume: 54, Issue: | Page From: 353, Page To: 358 | |
|
download file |
|